Xgeva Injection (Denosumab) is a drug of human monoclonal antibodies (IgG2 isotype) produced on the cell line of mammals using recombinant DNA technology. Xgeva Injection (Denosumab) prescribed for prevention of bone pathologies in patients with metastatic bone defeat by solid tumors.
